Type Size
Clinical Trials
UVA Islet Cell Transplantion in Patients with Type I Diabetes (KBL004)
IRB-HSR# 12839
Service:
Diabetes & Metabolism,
Kidney,
Transplantation
|
Category: Endocrinology, Nephrology (Kidney)
Adult Enrollment: Yes
|
Minor Enrollment: No
Primary Investigator: Kenneth Brayman, M.D., Ph.D.
Contact Information
Contact: Amy Fansler, M.P.H.
Phone: 434-243-6156
E-mail: acf7h@virginia.edu
Clinical Trial Description
UVA Health System, Department of Surgery, Transplant Division seeks adults ages 18-65 with Type 1 diabetes who have problems with very low blood sugars for a research study. Patients may have had previous kidney transplant.
The purpose of the study is to offer pancreatic islet cell transplantation to Type 1 diabetics who have trouble controlling their blood sugars with daily insulin and diet. Study involves numerous visits in the first several months post transplant, with periodic visits for up to 5 years.
Study-related exams, tests and some medications provided free of charge.
Compensation
No compensation is provided for this study.
